BRD-K98645985
|
|
|
- CAS号:
- 1357647-78-9
- 英文名:
- BRD-K98645985
- 英文别名:
- BRD-K98645985;BRD K98645985,BRD-K-98645985,BRDK98645985;Urea, N-(1-methylethyl)-N'-[(3S,6S,7R)-3,4,5,6,7,8,9,10-octahydro-7-methoxy-3,6,9-trimethyl-10-oxo-4-[[4-(2-pyridinyl)phenyl]methyl]-2H-1,4,9-benzoxadiazacyclododecin-12-yl]-
- 中文名:
- BRD-K98645985
- 中文别名:
- 化合物 T10605;BRD-K98645985
- CBNumber:
- CB08024433
- 分子式:
- C33H43N5O4
- 分子量:
- 573.73
- MOL File:
- 1357647-78-9.mol
|
|
|
BRD-K98645985化学性质
-
沸点:
-
699.4±55.0 °C(Predicted)
-
|
-
密度:
-
1.20±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
酸度系数(pKa):
-
13.73±0.46(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to light brown
-
|
BRD-K98645985性质、用途与生产工艺
BRD-K98645985 是一种 BAF (mammalian SWI/SNF) 转录阻遏的抑制剂，EC50 为 ~2.37 µM。BRD-K98645985 结合 ARID1A 特异的 BAF 复合物，防止核小体定位，并有效逆转 HIV-1 潜伏期，并且无 T 细胞毒性。
|
BAF transcriptional repression
2.37 μM (EC
50
)
|
HIV-1
|
BRD-K98645985 (30 µM; 18 hours) treatment shows a 5-fold increase in
Bmi1
, 2.6-fold increase in
Ring1
, and 3.3-fold decrease in
Fgf4
.
BRD-K98645985 treatment shows a concentration dependent latency reversal in J-Lat T-cell line models. BRD-K98645985 can be combined with other LRAs to improve reservoir targeting.
BRD-K98645985
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/08/19 | HY-114268 | BRD-K98645985
BRD-K98645985 | 1357647-78-9 | 1mg | 5000元 |
| 2023/10/26 | HY-114268 | BRD-K98645985
BRD-K98645985 | 1357647-78-9 | 5mg | 38000元 |
1357647-78-9, BRD-K98645985 相关搜索:
- 化合物 T10605
- BRD-K98645985
- 1357647-78-9
- Urea, N-(1-methylethyl)-N'-[(3S,6S,7R)-3,4,5,6,7,8,9,10-octahydro-7-methoxy-3,6,9-trimethyl-10-oxo-4-[[4-(2-pyridinyl)phenyl]methyl]-2H-1,4,9-benzoxadiazacyclododecin-12-yl]-
- BRD K98645985,BRD-K-98645985,BRDK98645985
- BRD-K98645985